Details of the Drug Reposition

General Information of This Drug (ID: DM3AD65)

Drug Name
EGFR806-specific CAR T cell   DM3AD65
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pineoblastoma DISQK8F3 2A00.20 Phase 1 [1]
Choroid plexus carcinoma DISQ04MQ 2A02.12 Phase 1 [1]
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1 [1]
Germ cell tumour DISOF3TK 2C80.2 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03638167) EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors